Related Experiment Video
Updated: Jun 25, 2026
09:16
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Runx1 promotes B-cell survival and lymphoma development
Karen Blyth1, Nicholas Slater, Linda Hanlon
1Faculty of Veterinary Medicine, Molecular Oncology Laboratory, Institute of Comparative Medicine, University of Glasgow, Glasgow, UK.
Blood Cells, Molecules & Diseases
|March 10, 2009
Summary
Runx1 (Runt-related transcription factor 1) is crucial for blood cell development. This study shows that increased Runx1 expression can promote leukemia development in lymphoid tissues, suggesting a gain-of-function role in cancer.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Runx1 (Runt-related transcription factor 1) is vital for normal hematopoiesis and lymphoid development.
- While RUNX1 loss-of-function mutations are linked to leukemia, Runx genes may also promote cancer.
- The oncogenic potential of Runx1 in lymphoid lineages requires further investigation.
Purpose of the Study:
- To investigate the effects of enforced Runx1 expression in lymphoid lineages.
- To determine if increased Runx1 levels can promote lymphomagenesis.
- To clarify the role of Runx1 gain-of-function in leukemia etiology.
Main Methods:
- In vivo and in vitro studies using enforced Runx1 expression in lymphoid cells.
- Assessment of cell survival and progenitor expansion.
- Analysis of Myc-induced lymphomagenesis in B and T cell lineages.
Main Results:
- Enforced Runx1 expression enhanced cell survival in the thymus and bone marrow.
- Increased Runx1 inhibited hematopoietic and B cell progenitor expansion in vitro.
- Modestly elevated Runx1 levels accelerated Myc-induced lymphomagenesis in both B and T cell lineages.
Conclusions:
- Wild-type Runx1 can promote oncogenesis in lymphoid tissues.
- Gain-of-function of Runx1, in addition to loss-of-function, plays a role in leukemia development.
- These findings highlight Runx1 as a potential therapeutic target in lymphoid malignancies.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...